This article explores the role of sleep as a pathological mechanism to fibromyalgia and the currently available pharmacological treatments for improving sleep in fibromyalgia.
Chronic lack of sleep or irregular sleep-wake cycles have been implicated as potentially key factors in the development of idiopathic Parkinson’s disease.
Differences in the levels of neurotransmitters GABA and glutamate have been observed in patients with obstructive sleep apnea compared with healthy controls.
Brain autopsies of elderly individuals indicate potential link between sleep fragmentation and arteriosclerosis and minor infarcts.
A research initiative exploring the usefulness of genetic information in a clinical setting has discovered six genes that appear to affect human sleep duration.
A new study has analyzed the role of secondary eating and drinking in an effort to unravel the mechanism behind the well-known association between sleep and obesity.
New research highlights a compound closely linked to orexin as a potentially important treatment for narcolepsy.
The use of dopamine agonists for Parkinson’s treatment is often associated with unwanted side effects. This review identifies strategies for managing or avoiding these effects and discusses future needs to improve the understanding of these phenomena.
Sleeping for less than 6 hours or more than 10 hours per night could increase the likelihood of suffering from low-grade inflammation in aging men.